Skip to content

Clinical trials

Completed Overweight trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Completed Country / region: Brazil Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20081
20095
20101
20112
20123
20142
20151
20171
20183
20192
20201
20215
20221
20237
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
Novo Nordisk A/S4
University of Sao Paulo General Hospital3
Federal University of Health Science of Porto Alegre2
Federal University of Minas Gerais2
Universidade Federal do Rio de Janeiro2
University of Campinas, Brazil2
University of Sao Paulo2
Centro Mente Aberta de Mindfulness1
Edgard Costa de Vilhena1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight40
Obesity35
Diabetes Mellitus, Type 26
Nutrition Disorders4
Prediabetic State2
Sleep Apnea, Obstructive2
Weight Loss2
Anemia1
Body Weight Changes1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.